2023
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Bhatia S, Pappo A, Acquazzino M, Allen-Rhoades W, Barnett M, Borinstein S, Casey R, Choo S, Chugh R, Dinner S, Ermoian R, Fair D, Federman N, Folbrecht J, Gandhi S, Germann J, Goldsby R, Hayashi R, Huang A, Huang M, Jacobs L, Lee-Miller C, Link M, Livingston J, Lustberg M, Malogolowkin M, Oeffinger K, Pratilas C, Reed D, Skiles J, von Mehren M, Yeager N, Montgomery S, Hang L. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2023, 21: 851-880. PMID: 37549914, DOI: 10.6004/jnccn.2023.0040.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAgedCounselingHumansMedical OncologyNeoplasmsRisk FactorsSurvivorshipYoung AdultConceptsYoung Adult OncologyAYA patientsAdult oncologyNCCN guidelinesNCCN Clinical Practice GuidelinesClinical practice guidelinesSupportive care servicesFertility counselingRisk factorsComprehensive carePractice guidelinesCare servicesPatientsOlder adultsOncologyCancerUnique needsGuidelinesAdolescentsBehavioral issuesDiagnosisCareThe Rise of Supportive Oncology: A Revolution in Cancer Care
Berman R, Laird B, Minton O, Monnery D, Ahamed A, Boland E, Droney J, Vidrine J, Leach C, Scotté F, Lustberg M, Lacey J, Chan R, Duffy T, Noble S. The Rise of Supportive Oncology: A Revolution in Cancer Care. Clinical Oncology 2023, 35: 213-215. PMID: 36737312, DOI: 10.1016/j.clon.2023.01.015.Peer-Reviewed Original Research
2020
Palliative Care Referral Patterns for Adolescent and Young Adult Patients at a Comprehensive Cancer Center
Lockwood BJ, Ntukidem OL, Ehrman SE, Schnell PM, Klemanski DL, Bhatnagar B, Lustberg M. Palliative Care Referral Patterns for Adolescent and Young Adult Patients at a Comprehensive Cancer Center. Journal Of Adolescent And Young Adult Oncology 2020, 10: 109-114. PMID: 32706607, DOI: 10.1089/jayao.2020.0081.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentHumansMedical OncologyNeoplasmsPalliative CareReferral and ConsultationRetrospective StudiesYoung AdultConceptsPalliative careReferral patternsHigh symptom burdenRetrospective chart reviewYoung adult patientsComprehensive cancer centerEligible patientsSpecific cancer typesAdult patientsChart reviewSymptom burdenOncologic treatmentCancer CenterLung cancerInpatient settingPoor survivalCancer typesPatientsYoung adultsCancerGreater penetranceSmall percentageAdolescentsValuable rolePC access
2007
Optimal Duration of Chemotherapy in Advanced Non-Small Cell Lung Cancer
Lustberg M, Edelman M. Optimal Duration of Chemotherapy in Advanced Non-Small Cell Lung Cancer. Current Treatment Options In Oncology 2007, 8: 38-46. PMID: 17634834, DOI: 10.1007/s11864-007-0020-6.Peer-Reviewed Original ResearchConceptsPlatinum-based chemotherapyQuality of lifeLung cancerNew agentsAdvanced non-small cell lung cancerOptimal durationNon-small cell lung cancerPlatinum-based combination chemotherapyEpidermal growth factor receptor inhibitorsGrowth factor receptor inhibitorsBenefit of chemotherapyFirst-line chemotherapyAdditional survival benefitAdvanced stage diseaseDuration of therapyMetastatic lung cancerCell lung cancerMatrix metalloproteinase inhibitorsCytotoxic regimenPlatinum doubletsLine chemotherapySequential therapyStage diseaseCombination chemotherapyOverall survival